Free morning briefing · 07:30 weekdays
The RNS that moves prices, in your inbox before the open.
AI-ranked movers and high-impact RNS across the FTSE 100, 250, SmallCap and AIM — one short email, every market day.
Get the briefing
BVXP

Bioventix PLC

BVXPLSEUnited KingdomHealthcareBiotechnologyAIM

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. It offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; Pyrene 1-hydroxypyrene glucuronide…more

P/E14.60xP/B9.47xROIC116.9%Dividend yield7.5%
£104.50M
Market Cap
EV: £99.20M
MOM1
QUAL5
VAL5
RSK4
BVXP
£104.50M
Market Cap · EV £99.20M

Bioventix PLC

MOM1
QUAL5
VAL5
RSK4

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. It offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; Pyrene 1-hydroxypyrene glucuronide…more

Latest RNS from Bioventix PLC

Analyst consensus: Buy

As of 10 Nov 2026, 1 analyst rate Bioventix PLC a Buy, with 100% buy ratings and a mean price target of 3,900p (range 3,900p–3,900p), +109% vs the current price.

Strong buy: 0Buy: 1Hold: 0Sell: 0Strong sell: 0

Full analyst history →

More Healthcare companies